Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@BioTechHealthX Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1387526045134462978.png) @BioTechHealthX BioTech Health X

BioTech Health X posts on X about launches, upside, $unh, $azn the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1387526045134462978/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1387526045134462978/c:line/m:interactions.svg)

- X Week XXXXX +47%
- X Month XXXXX +69%
- X Months XXXXXX +4,133%
- X Year XXXXXX +6,382%

### Mentions: XX [#](/creator/twitter::1387526045134462978/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1387526045134462978/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XX +13%
- X Months XXX +13,400%
- X Year XXX +4,400%

### Followers: XXX [#](/creator/twitter::1387526045134462978/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1387526045134462978/c:line/m:followers.svg)

- X Week XXX +1.10%
- X Month XXX +5.40%
- X Months XXX +26%
- X Year XXX +31%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1387526045134462978/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1387526045134462978/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1387526045134462978/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXX% [finance](/list/finance)  XXX% [currencies](/list/currencies)  XXXX% [cryptocurrencies](/list/cryptocurrencies)  XXXX%

**Social topic influence**
[launches](/topic/launches) 2.5%, [upside](/topic/upside) 2.5%, [$unh](/topic/$unh) 1.25%, [$azn](/topic/$azn) 1.25%, [$80b](/topic/$80b) 1.25%, [$tnxp](/topic/$tnxp) 1.25%, [longterm](/topic/longterm) 1.25%, [$hca](/topic/$hca) 1.25%, [$argx](/topic/$argx) 1.25%, [$45b](/topic/$45b) XXXX%

**Top accounts mentioned or mentioned by**
[@corcept](/creator/undefined) [@unitedhealthgrp](/creator/undefined) [@jnj](/creator/undefined) [@kuraoncologys](/creator/undefined) [@astrazeneca](/creator/undefined) [@tonixpharma](/creator/undefined) [@abeonabio](/creator/undefined) [@teamnovonordisk](/creator/undefined) [@hcahealthcare](/creator/undefined) [@argenxglobal](/creator/undefined) [@acadiapharmas](/creator/undefined) [@krystalbiotech](/creator/undefined) [@apellispharma](/creator/undefined) [@lakesideholding](/creator/undefined) [@zimmerbiomet](/creator/undefined) [@pelthost](/creator/undefined) [@acadiahealthca1](/creator/undefined) [@halozymeinc](/creator/undefined) [@meiragtx](/creator/undefined) [@immunitybio](/creator/undefined)

**Top assets mentioned**
[UnitedHealth Group (UNH)](/topic/$unh) [AstraZeneca PLC (AZN)](/topic/$azn) [HCA Healthcare Inc (HCA)](/topic/$hca) [Corcept Therapeutics Inc. (CORT)](/topic/$cort) [UPCX (UPC)](/topic/$upc) [4 (4)](/topic/$4) [Tarsus Pharmaceuticals, Inc. Common Stock (TARS)](/topic/$tars) [Akropolis (AKRO)](/topic/$akro) [Fresenius Medical Care AG & Co. KGaA (FMS)](/topic/$fms) [Molina Healthcare, Inc. (MOH)](/topic/$moh) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS)](/topic/$nams) [Elevance Health Inc (ELV)](/topic/$elv) [Laboratory Corp. of America Holdings (LH)](/topic/$lh)
### Top Social Posts [#](/creator/twitter::1387526045134462978/posts)
---
Top posts by engagements in the last XX hours

"$UNH @UnitedHealthGrp delivers $XXXXXX billion in revenue yet EPS falls short spotlighting margin challenges in a costly healthcare climate"  
[X Link](https://x.com/BioTechHealthX/status/1976828621403918451) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-11T01:54Z XXX followers, XXX engagements


"$AZN @AstraZeneca eyes $80B in annual revenue by 2030 driven by XX new drug launches and booming oncology sales"  
[X Link](https://x.com/BioTechHealthX/status/1978047447760015442) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-14T10:37Z XXX followers, XX engagements


"$TNXP @TonixPharma shares fall despite FDA approval for Tonmya. Analysts say the sell-off could be a golden opportunity for long-term investors"  
[X Link](https://x.com/BioTechHealthX/status/1978047574411272323) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-14T10:37Z XXX followers, XXX engagements


"$HCA @HCAhealthcare has soared from $XXX to over $XXX per share. With rising earnings estimates can HCA keep climbing higher"  
[X Link](https://x.com/BioTechHealthX/status/1960350057712251122) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-08-26T14:34Z XXX followers, XXX engagements


"$ARGX @argenxglobal soared to $XXXXXX fueled by XX% year-over-year revenue growth and record Vyvgart sales. Can the $45B biotech keep its momentum"  
[X Link](https://x.com/BioTechHealthX/status/1976237900292661498) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-09T10:46Z XXX followers, XX engagements


"$CORT @Corcept has delivered a jaw-dropping 1534% gain in the last decade. With FDA review of relacorilant underway can this stock keep climbing"  
[X Link](https://x.com/BioTechHealthX/status/1973257534648754501) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-01T05:23Z XXX followers, XX engagements


"$UPC Universe Pharmaceuticals shares skyrocketed XX% this week climbing from $X to $X amid speculation and strong volume. Is it a turnaround or another biotech bubble"  
[X Link](https://x.com/BioTechHealthX/status/1976237703739134397) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-09T10:45Z XXX followers, XX engagements


"$TARS Tarsus shares jump XXXX% to $XXXXX as XDEMVY racks up $XXX million in first-half 2025 sales one of the fastest-growing eye drop launches"  
[X Link](https://x.com/BioTechHealthX/status/1976143428372086932) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-09T04:31Z XXX followers, XXX engagements


"$AKRO Akero Therapeutics jumps XXXXX% as new clinical data for efruxifermin shows major liver health gains in MASH patients"  
[X Link](https://x.com/BioTechHealthX/status/1978047322513871146) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-14T10:36Z XXX followers, XX engagements


"$EBS Down from $1B in prior years @EmergentLabsHQ's trailing twelve-month revenue exposes how hard its recovery journey has become"  
[X Link](https://x.com/BioTechHealthX/status/1976828927424528709) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-11T01:55Z XXX followers, XXX engagements


"$AXGN Revenue jumped XXXX% year-over-year as Axogen nears its FDA BLA decision. Analysts project up to XX% upside before the December X ruling"  
[X Link](https://x.com/BioTechHealthX/status/1977420465649115281) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-12T17:05Z XXX followers, XX engagements


"$FMS With shares trading around $XX ongoing product recalls & looming reimbursement cuts continue to cloud @Fresenius' recovery outlook"  
[X Link](https://x.com/BioTechHealthX/status/1977421203972444385) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-12T17:08Z XXX followers, XX engagements


"$MOH Molina Healthcares shares plunged XXXXX% in XX months after cutting EPS guidance amid soaring medical costs. Is a turnaround possible"  
[X Link](https://x.com/BioTechHealthX/status/1978047106062684517) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-14T10:35Z XXX followers, XX engagements


"$REGN The Phase X C-POST trial proved Libtayo cut cancer recurrence risk by XX% yet @Regeneron tumbled 3%. What spooked investors"  
[X Link](https://x.com/BioTechHealthX/status/1976143068140347784) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-09T04:29Z XXX followers, XX engagements


"$TVRD Retail investors own XX% of Tvardi giving them real control as Phase X data nears. Could this be Wall Streets next retail-driven breakout"  
[X Link](https://x.com/BioTechHealthX/status/1977804112512328114) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-13T18:30Z XXX followers, XXX engagements


"$NAMS NewAmsterdam Pharma rockets nearly XX% year-over-year as investors bet big on its late-stage cholesterol drug obicetrapib"  
[X Link](https://x.com/BioTechHealthX/status/1978443135391871213) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-15T12:49Z XXX followers, XXX engagements


"$ELV Trading at just XXXXX forward earnings vs. the industrys XXXX @ElevanceHealth's strategy could offer a major rebound opportunity"  
[X Link](https://x.com/BioTechHealthX/status/1976143799165624453) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-09T04:32Z XXX followers, XX engagements


"$LH With EPS set to jump XX% this year investors see upside for @Labcorp's $19.5B diagnostics empire"  
[X Link](https://x.com/BioTechHealthX/status/1977421022988308755) [@BioTechHealthX](/creator/x/BioTechHealthX) 2025-10-12T17:08Z XXX followers, XX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BioTechHealthX Avatar @BioTechHealthX BioTech Health X

BioTech Health X posts on X about launches, upside, $unh, $azn the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Week XXXXX +47%
  • X Month XXXXX +69%
  • X Months XXXXXX +4,133%
  • X Year XXXXXX +6,382%

Mentions: XX #

Mentions Line Chart

  • X Week XX -XX%
  • X Month XX +13%
  • X Months XXX +13,400%
  • X Year XXX +4,400%

Followers: XXX #

Followers Line Chart

  • X Week XXX +1.10%
  • X Month XXX +5.40%
  • X Months XXX +26%
  • X Year XXX +31%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence stocks XXXX% finance XXX% currencies XXXX% cryptocurrencies XXXX%

Social topic influence launches 2.5%, upside 2.5%, $unh 1.25%, $azn 1.25%, $80b 1.25%, $tnxp 1.25%, longterm 1.25%, $hca 1.25%, $argx 1.25%, $45b XXXX%

Top accounts mentioned or mentioned by @corcept @unitedhealthgrp @jnj @kuraoncologys @astrazeneca @tonixpharma @abeonabio @teamnovonordisk @hcahealthcare @argenxglobal @acadiapharmas @krystalbiotech @apellispharma @lakesideholding @zimmerbiomet @pelthost @acadiahealthca1 @halozymeinc @meiragtx @immunitybio

Top assets mentioned UnitedHealth Group (UNH) AstraZeneca PLC (AZN) HCA Healthcare Inc (HCA) Corcept Therapeutics Inc. (CORT) UPCX (UPC) 4 (4) Tarsus Pharmaceuticals, Inc. Common Stock (TARS) Akropolis (AKRO) Fresenius Medical Care AG & Co. KGaA (FMS) Molina Healthcare, Inc. (MOH) Regeneron Pharmaceuticals Inc (REGN) NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) Elevance Health Inc (ELV) Laboratory Corp. of America Holdings (LH)

Top Social Posts #


Top posts by engagements in the last XX hours

"$UNH @UnitedHealthGrp delivers $XXXXXX billion in revenue yet EPS falls short spotlighting margin challenges in a costly healthcare climate"
X Link @BioTechHealthX 2025-10-11T01:54Z XXX followers, XXX engagements

"$AZN @AstraZeneca eyes $80B in annual revenue by 2030 driven by XX new drug launches and booming oncology sales"
X Link @BioTechHealthX 2025-10-14T10:37Z XXX followers, XX engagements

"$TNXP @TonixPharma shares fall despite FDA approval for Tonmya. Analysts say the sell-off could be a golden opportunity for long-term investors"
X Link @BioTechHealthX 2025-10-14T10:37Z XXX followers, XXX engagements

"$HCA @HCAhealthcare has soared from $XXX to over $XXX per share. With rising earnings estimates can HCA keep climbing higher"
X Link @BioTechHealthX 2025-08-26T14:34Z XXX followers, XXX engagements

"$ARGX @argenxglobal soared to $XXXXXX fueled by XX% year-over-year revenue growth and record Vyvgart sales. Can the $45B biotech keep its momentum"
X Link @BioTechHealthX 2025-10-09T10:46Z XXX followers, XX engagements

"$CORT @Corcept has delivered a jaw-dropping 1534% gain in the last decade. With FDA review of relacorilant underway can this stock keep climbing"
X Link @BioTechHealthX 2025-10-01T05:23Z XXX followers, XX engagements

"$UPC Universe Pharmaceuticals shares skyrocketed XX% this week climbing from $X to $X amid speculation and strong volume. Is it a turnaround or another biotech bubble"
X Link @BioTechHealthX 2025-10-09T10:45Z XXX followers, XX engagements

"$TARS Tarsus shares jump XXXX% to $XXXXX as XDEMVY racks up $XXX million in first-half 2025 sales one of the fastest-growing eye drop launches"
X Link @BioTechHealthX 2025-10-09T04:31Z XXX followers, XXX engagements

"$AKRO Akero Therapeutics jumps XXXXX% as new clinical data for efruxifermin shows major liver health gains in MASH patients"
X Link @BioTechHealthX 2025-10-14T10:36Z XXX followers, XX engagements

"$EBS Down from $1B in prior years @EmergentLabsHQ's trailing twelve-month revenue exposes how hard its recovery journey has become"
X Link @BioTechHealthX 2025-10-11T01:55Z XXX followers, XXX engagements

"$AXGN Revenue jumped XXXX% year-over-year as Axogen nears its FDA BLA decision. Analysts project up to XX% upside before the December X ruling"
X Link @BioTechHealthX 2025-10-12T17:05Z XXX followers, XX engagements

"$FMS With shares trading around $XX ongoing product recalls & looming reimbursement cuts continue to cloud @Fresenius' recovery outlook"
X Link @BioTechHealthX 2025-10-12T17:08Z XXX followers, XX engagements

"$MOH Molina Healthcares shares plunged XXXXX% in XX months after cutting EPS guidance amid soaring medical costs. Is a turnaround possible"
X Link @BioTechHealthX 2025-10-14T10:35Z XXX followers, XX engagements

"$REGN The Phase X C-POST trial proved Libtayo cut cancer recurrence risk by XX% yet @Regeneron tumbled 3%. What spooked investors"
X Link @BioTechHealthX 2025-10-09T04:29Z XXX followers, XX engagements

"$TVRD Retail investors own XX% of Tvardi giving them real control as Phase X data nears. Could this be Wall Streets next retail-driven breakout"
X Link @BioTechHealthX 2025-10-13T18:30Z XXX followers, XXX engagements

"$NAMS NewAmsterdam Pharma rockets nearly XX% year-over-year as investors bet big on its late-stage cholesterol drug obicetrapib"
X Link @BioTechHealthX 2025-10-15T12:49Z XXX followers, XXX engagements

"$ELV Trading at just XXXXX forward earnings vs. the industrys XXXX @ElevanceHealth's strategy could offer a major rebound opportunity"
X Link @BioTechHealthX 2025-10-09T04:32Z XXX followers, XX engagements

"$LH With EPS set to jump XX% this year investors see upside for @Labcorp's $19.5B diagnostics empire"
X Link @BioTechHealthX 2025-10-12T17:08Z XXX followers, XX engagements

creator/x::BioTechHealthX
/creator/x::BioTechHealthX